Effect of Different Chinese Herbal Compound on Type Ⅰ,Ⅲ Collagen in Myocardium of Rats with Heart Failure Following Myocardial Infarction

doi:10.3969/j.issn.1007-9572.2016.36.021

Abstract

Abstract: Objective　To observe the effect of different Chinese herbal compound on type Ⅰ,Ⅲ collagen in myocardium of rats with heart failure following myocardial infarction.Methods　From April 2010 to January 2011,the rat model of heart failure following myocardial infarction were established by coronary artery ligation method and exhaustive swimming.The experimental rats were divided into model group,western medicine group,Reinforcing qi group,Activating blood group,Reinforcing qi and activating blood group,and control group.10 rats in each group.Real time fluorescence quantitative PCR and immunohistochemistry were used to detect the expression of type Ⅰ,Ⅲ collagen in the myocardium of rats with heart failure following myocardial infarction.Results　Compared with control group,the expression of type Ⅰ,Ⅲ collagen in model group detected by PCR and immunohistochemistry significantly decreased （P<0.05）.Compared with model group,the expression of type Ⅰ,Ⅲ collagen in each treatment groups detected by PCR and immunohistochemistry significantly increased （P<0.05）.The expression of type Ⅰ,Ⅲ collagen in western medicine group and Reinforcing qi and Activating blood group detected by PCR and immunohistochemistry were significantly higher than Reinforcing qi group and Activating blood group （P<0.05）.Conclusion　Reinforcing qi and activating blood Chinese herbal compound can improve the expression of type Ⅰ,Ⅲ collagen in myocardium of rats with heart failure following myocardial infarction,thus achieve the role of treatment of heart failure.

Key words: Reinforcing qi activat blood, Heart failure, Myocardial infarction, Collagen type I, Collagen type Ⅲ

摘要： 目的　观察不同中药复方对心肌梗死后心力衰竭大鼠心肌组织中Ⅰ、Ⅲ型胶原的影响。方法　2010年4月—2011年1月，以冠状动脉结扎配合力竭式游泳的方法造成心肌梗死后心力衰竭大鼠模型，分为模型组、西药组、益气组、活血组、益气活血组，另设空白对照组。每组10只大鼠。采用实时荧光定量PCR及免疫组化检测心肌梗死后心力衰竭大鼠心肌组织中Ⅰ、Ⅲ型胶原的表达。结果　实时荧光定量PCR和免疫组化结果均显示：与空白对照组比较,模型组大鼠Ⅰ、Ⅲ型胶原表达下降（P<0.05）；与模型组比较,各给药组大鼠Ⅰ、Ⅲ型胶原表达升高（P<0.05）；西药组、益气活血组大鼠Ⅰ、Ⅲ型胶原表达高于益气组及活血组（P<0.05）。结论　益气活血中药复方较益气中药复方、活血中药复方更能提高心肌梗死后心力衰竭大鼠心肌组织中Ⅰ、Ⅲ型胶原的表达，可达到治疗心力衰竭的作用。

关键词: 益气活血, 心力衰竭, 心肌梗死, 胶原Ⅰ型, 胶原Ⅲ型

ZHANG Yang, ZHANG Yan, ZHANG Hong. Effect of Different Chinese Herbal Compound on Type Ⅰ,Ⅲ Collagen in Myocardium of Rats with Heart Failure Following Myocardial Infarction[J]. Chinese General Practice, 2016, 19(36): 4509-4514.

张洋, 张艳, 张红. 不同中药复方对心肌梗死后心力衰竭大鼠心肌Ⅰ、Ⅲ型胶原的影响[J]. 中国全科医学, 2016, 19(36): 4509-4514.

References

［1］甄洁，李晓霞.有氧运动抑制心梗后心力衰竭大鼠左室重塑及交感神经重塑［J］.中国病理生理杂志，2015,31（6）：973-979. ZHEN J，LI X X.Inhibitory effect of aerobic exercise on left ventricular remodeling and sympathetic neural remodeling in rats with heart failure after myocardial infarction［J］.Chinese Journal of Pathophysiology，2015，31（6）:973-979 ［2］张玉珠，张艳，王辰，等.不同益气活血中药组方对心衰大鼠MMP-9影响的实验研究［J］.辽宁中医药大学学报，2013，15（9）:8-11. ZHANG Y Z，ZHANG Y，WANG C，et al.Experiment research on effect of different chinese medicine compound on MMP-9 expressions in rats with chronic heart failure［J］.Journal of Liaoning University of TCM，2013，15（9）:8-11. ［3］礼海.益气活血复方对慢性心衰大鼠心肌MMP-1、TIMP-1影响相关性及抗心室重构机制的研究［D］.沈阳：辽宁中医药大学，2010. LI H.Yiqi huoxue compound for chronic heart failure rats myocardial MMP-1 and TIMP-1 influence relevance and ventricular remodeling mechanism research ［D］.Shenyang:Liaoning University of Chinese Medicine,2010. ［4］马金.益气活血复方联合运动训练对慢性心衰大鼠的心功能及左室重构影响的实验研究［D］.沈阳：辽宁中医药大学，2011. MA J.Yiqi huoxue compound joint exercise training on chronic heart failure rat experimental study on the impact of the cardiac function and left ventricular remodeling ［D］.Shenyang:Liaoning University of Chinese Medicine,2011. ［5］李军，吕双红，薛剑，等.大鼠心肌梗死后心力衰竭模型的建立及评价［J］.标记免疫分析与临床，2015，22（10）:1037-1041. LI J，LYU S H，XUE J，et al.Establishment and evaluation of heart failure model after myocardial infarction in rats［J］.Labeled Immunoassays and Clinical Medicine,2015,22（10）:1037-1041. ［6］张艳，廖佳丹，王彩玲.益气活血利水不同配伍对慢性心衰大鼠MMP-9影响的实验研究［J］.时珍国医国药，2012，23（8）:1937-1939. ZHANG Y，LIAO J D，WANG C L.Yiqi huoxue benefit water different compatibility on the impact of chronic heart failure rats MMP-9 experimental research［J］.Lishizhen Medicine and Materia Medica Research，2012，23（8）:1937-1939. ［7］张艳，胡晓红，廖佳丹，等.不同中药复方对慢性心衰大鼠MMP-2、TIMP-2影响的实验研究［J］.辽宁中医杂志，2012，39（7）:1205-1207. ZHANG Y，HU X H，LIAO J D，et al.Experiment research on effect of different chinese medicine compound on MMP-2 and TIMP-2 expressions in rats with chronic heart failure［J］.Liaoning Journal of TCM,2012，39（7）:1205-1207. ［8］廖佳丹，张艳，宫丽鸿，等.益气活血利水不同配伍对慢性心衰大鼠AT1、ERK2影响的实验研究［J］.中华中医药学刊，2012，30（10）:2270-2273. LIAO J D,ZHANG Y，GONG L H，et al.Effect of Supplementing qi，activating blood circulation and diuresis Chinese herbs compound prescription on AT1，ERK2 expression in rats with chronic heart failure［J］.Chinese Archives of Traditional Chinese Medicine，2012，30（10）:2270-2273. ［9］宫丽鸿，张艳，高峰.益气活血复方对慢性心力衰竭大鼠心肌组织MMP-1、Ⅰ型胶原、BNP的影响［J］.中西医结合心脑血管病杂志，2011，9（2）:189-190. GONG L H，ZHANG Y，GAO F.Supplementing qi and activating blood compound prescription effect of different chinese medicine compound on MMP-9 expressions in rats with chronic heart failure［J］.Chinese Journal of Integrative Medicine on Cardio Disease,2011，9（2）:189-190. ［10］国家药典编委会.《中国药典》2010版一部［M］.北京：中国医药科技出版社，2010:25-38. National pharmacopoeia editorial committee.Chinese pharmacopoeia 2010 edition first part ［M］.Beijing: China Medical Science and Technology Press,2010:25-38. ［11］王懿，张艳，礼海.益气活血方干预PGC-1α调控心衰心肌细胞能量代谢重构的作用机制［J］.中国实验方剂学杂志，2015，21（6）:169-173. WANG Y，ZHANG Y，LI H.Mechanism of action research on Yiqi Huoxue decoction intervene PGC-1α control heart failure myocardial cell energy metabolismrefactoring［J］.Chinese Journal of Experimental Traditional Medical Formulae，2015，21（6）:169-173. ［12］马金，张艳,礼海.益气活血复方配合运动训练对慢性心衰大鼠心肌组织MMP-1、Ⅲ型胶原蛋白影响的实验研究［J］.时珍国医国药，2011，38（5）:863-865. MA J，ZHANG Y，LI H.Yiqi huoxue compound with exercise training on chronic heart failure rats myocardial tissue MMP-1,Ⅲ type collagen impact experimental study［J］.Lishizhen Medicine and Materia Medica Research，2011，38（5）:863-865. ［13］马金，张艳.益气活血复方对慢性心衰大鼠心肌重构影响的实验研究［J］.时珍国医国药，2011，22（6）:1361-1362. MA J，ZHANG Y.Yiqi huoxue compound on the impact of chronic heart failure rats myocardial remodeling experiment research［J］.Lishizhen Medicine and Materia Medica Research，2011，22（6）:1361-1362. ［14］张艳，礼海，王彩玲.浅谈慢性心衰中医病名病机研究［J］.时珍国医国药，2011，21（6）:1547-1548. ZHANG Y，LI H，WANG C L.Introduction to chronic heart failure disease pathogenesis of traditional Chinese medicine research［J］.Lishizhen Medicine and Materia Medica Research，2011，21（6）:1547-1548. ［15］郑辉，徐重白.益气活血法治疗心力衰竭临床研究［J］.吉林中医药，2013，33（3）:235-236. ZHENG H，XU C B.Yiqi huoxue method of treatment of heart failure in clinical research［J］.Jilin Journal of Traditional Chinese Medicine，2013，33（3）:235-236. ［16］任亚丽，徐济良，虞珏，等.苯那普利与厄贝沙坦对心衰大鼠心肌胶原的影响及机制探讨［J］.中国药理学通报，2015,31（7）:1009-1014. REN Y L，XU J L，YU Y，et al.Effects of benazepril and irbesartan on myocardial collagen in chronic heart failure rats and mechanisms［J］.Chinese Pharmacological Bulletin，2015,31（7）:1009-1014. ［17］贾政，魏玲，刘茜，等.重组腺病毒介导Klotho基因转导对大鼠心力衰竭心肌重构的影响［J］.中华心血管病杂志，2015，43（3）:219-226. JIA Z，WEI L，LIU Q，et al.Recombinant adenovirus mediated Klotho gene transduction effect on rat myocardial remodeling of heart failure［J］.Chinese Journal of Cardiovascular Disease,2015,43 （3）:219-226. ［18］张洋.益气活血复对慢性心衰大鼠Ⅰ、Ⅲ型胶原表达影响的实验研究［D］.沈阳：辽宁中医药大学，2011. ZHANG Y.Supplementing qi and activating blood compound effect onⅠ,Ⅲ type collagen for chronic heart failure rats ［D］.Shenyang:Liaoning University of Chinese Medicine,2011.

[1]	WANG Lina, LEI Jingshu, LI Kuibao, WANG Ruiying, LI Xinmiao, WANG Fangfang, GUO Xiaorong, NIU Ruihao, ZHAO Wei, ZHOU Fangfang, ZHAO Jingjing, LEE CHONGYOU. Review on Inflammatory Response in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2026, 29(06): 790-801.
[2]	WANG Yiheng, XU Xiaoming, XIA Yunlong, XIA Linying, HAN Xue, GUO Yongzhen, LIU Quanchi, YAN Wenjun. Progress in Pharmacotherapy of Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2026, 29(03): 403-408.
[3]	JIANG Xiaorui, YAN Yuyao, WEI Jingjing, QIAO Lijie, PENG Guangcao, ZHU Mingjun. Systematic Review of Risk Prediction Models for Concurrent Heart Failure with Coronary Heart Disease [J]. Chinese General Practice, 2026, 29(03): 393-402.
[4]	CEN Kaiyuan, FATIMAH Ahmedy, CHEN Hong, SHAO Mingchen, MEXMOLLEN Marcus, MOHD Fadzli Shukor. Exercise-based Cardiac Rehabilitation in Acute Myocardial Infarction Management: Global Perspectives, Multimodal Interventions, and Personalized Strategies [J]. Chinese General Practice, 2025, 28(36): 4627-4639.
[5]	ZHAO Zhuo, WANG He. Research Progress on the Mechanism of HIF-2α in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(33): 4241-4248.
[6]	LIU Yongcheng, LIU Siyu, LIANG Xiaoyu, HAO Xiaopeng, WEI Yue, DONG Guoju. Analysis of Echocardiographic Outcome Measures in Randomized Controlled Trials in Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2025, 28(33): 4140-4147.
[7]	MA Shuangshuang, XING Yanjiang, ZHANG Jiawei, WANG Jing. Research Progress on Cardiac Energy Metabolic Changes in Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2025, 28(30): 3831-3840.
[8]	JIA Gaopeng, CHEN Qiuyu. Construction and Validation of a Risk Prediction Model for Recurrent Angina after Percutaneous Coronary Intervention in Elderly Patients with Acute ST-segment Elevation Myocardial Infarction: Based on CYP2C19-related Genetic Testing [J]. Chinese General Practice, 2025, 28(30): 3779-3786.
[9]	DENG Jie, QI Qi, WU Xinyu, HAN Quanle, LI Lei, JIANG Yue, YU Jing, WU Ruojie, WU Shouling, LI Kangbo. Cohort Study on the Association between the Atherogenic Index of Plasma and the Risk of Incident Heart Failure in a Physical Examination Population [J]. Chinese General Practice, 2025, 28(29): 3645-3652.
[10]	LIU Zhenyu, WEI Yunpeng, WANG Jiangmin, XING Yan. Causal Association Study between Sleep Duration and Heart Failure [J]. Chinese General Practice, 2025, 28(27): 3441-3446.
[11]	LIU Wenjie, SUN Huang, LUO Wei, CHEN Xuan, PENG Yunzhu, LI Ruijie, MA Mier. Wearable Acoustic-electrocardiographic Remote Monitoring Device for Heart Failure [J]. Chinese General Practice, 2025, 28(25): 3104-3109.
[12]	YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058.
[13]	HAN Bing, DU Shuzhen, MENG Xiaoxue, ZHANG Lu, CHEN Zixian, TENG Fengling. Plasma Periostin Levels Correlated with Myocardial Fibrosis in Patients with Heart Failure with Different Ejection Fraction [J]. Chinese General Practice, 2025, 28(24): 2979-2984.
[14]	WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992.
[15]	WANG Jiuge, ZHAN Wuyi, HE Anxia. The Impact of Early Microcirculation Perfusion after Percutaneous Coronary Intervention for Acute Myocardial Infarction on Left Ventricular Function [J]. Chinese General Practice, 2025, 28(23): 2878-2884.